Literature DB >> 1427906

Subregional mapping of 13 single-copy genes on the long arm of chromosome 12 by fluorescence in situ hybridization.

S Mathew1, V V Murty, W Hunziker, R S Chaganti.   

Abstract

Subregional localization of 13 single-copy DNA sequences previously assigned to the long arm of chromosome 12 has been performed using the fluorescence in situ hybridization (FISH) technique. The following order is suggested for the 13 mapped genes: cen-->COL2A1-->(VDR-D12S15)-->(D12S17-D12S4++ +-D12S14-D12S6)-->D12S8-->(IAPP-MGF- D12S7-D12S12)-->IGF1-->qter. Eight of the mapped genes clustered at two regions, one at 12q13 (D12S17-D12S4-D12S14-D12S6) and the other at 12q22 (IAPP-MGF-D12S7-D12S12). Our results show that single-copy DNA sequences as small as 500 bp can be successfully mapped by FISH.

Mesh:

Year:  1992        PMID: 1427906     DOI: 10.1016/s0888-7543(05)80184-3

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  5 in total

1.  Characterization of the promoter region of the gene for the rat neutral and basic amino acid transporter and chromosomal localization of the human gene.

Authors:  N Yan; R Mosckovitz; L D Gerber; S Mathew; V V Murty; S S Tate; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

2.  Expression of proto-oncogene KIT is up-regulated in subset of human meningiomas.

Authors:  Masum Saini; Ajaya Nand Jha; Andleeb Abrari; Sher Ali
Journal:  BMC Cancer       Date:  2012-06-06       Impact factor: 4.430

3.  Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta-analysis based on 39 case-control studies.

Authors:  Zhipeng Pan; Mengya Chen; Xingxing Hu; Hua Wang; Jiajia Yang; Congjun Zhang; Faming Pan; Guoping Sun
Journal:  Oncotarget       Date:  2018-01-04

4.  A candidate metastasis-associated DNA marker for ductal mammary carcinoma.

Authors:  Patnala Mohan R Achary; Hui Zhao; Zuoheng Fan; Swarna Gogineni; Venkat R Pulijaal; Lawrence Herbst; Panna S Mahadevia; Joan G Jones; Harold P Klinger; Bhadrasain Vikram
Journal:  Breast Cancer Res       Date:  2003-01-30       Impact factor: 6.466

Review 5.  Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.

Authors:  Ayalew Tefferi
Journal:  J Cell Mol Med       Date:  2008-10-23       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.